Latest News

Out of multiple potential risk factors for the development of preeclampsia, ranging from hypertension to non-gestational diabetes and maternal age > 35, researchers found that pre-pregnancy coronary artery calcium (CAC) was the only risk factor significantly associated with preeclampsia.

Catch up on the top radiology content of the past week.

For patients having CT angiography prior to TAVR procedures, researchers found that photon-counting detector CT (PCD-CT) offered higher specificity and PPV for detecting significant coronary artery disease (CAD), according to study findings to be presented at the Society of Cardiovascular Computed Tomography (SCCT) conference.

Photon-counting computed tomography (PCCT) is a foundational cornerstone that can facilitate detection, targeting and reversal of coronary artery disease.

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses pertinent principles, pearls and outcomes with Y90 radioembolization for the treatment of patients with liver cancer.

Researchers found that former NFL players had a 3.8-fold higher mortality rate for all-cause dementia and a nearly 3.9-fold higher mortality rate for Parkinson’s disease, according to a study involving over 19,800 former NFL players.

The Alturion ultrasound device reportedly combines portability, AI-enhanced capabilities and a user-friendly interface to facilitate streamlined workflows.

Deep learning-based motion correction with the CLEAR Motion software reportedly bolsters cardiac imaging quality while the PIQE 1024 Deep Learning Reconstruction software offers equivalent SNR to photon-counting CT for high-resolution views of objects less than 0.5 mm.

Researchers said the combination of 18F-flotufolastat PET/MRI may lead to a 57 percent reduction of prostate biopsies in comparison to a 25 percent reduction with prostate MRI alone.

In a recent interview, Nina Kottler, MD, offered her perspective on findings from a recent report on AI in health care, AI integration challenges and what the future holds with AI in radiology.

In comparison to everolimus, the peptide receptor radionuclide therapy (177Lu)Lu-edotreotide provided over a nine month longer median progression-free survival for patients with gastroenteropancreatic neuroendocrine tumours (GEP NETs), according to new phase 3 research.

In an amusing take on the subject, this author suggests that having a colleague with dedicated expertise in curtailing unnecessary imaging requests could have an impact in reducing burgeoning worklists.

Catch up on the top radiology content of the past week.